Statistical analysis plan for the HEAT trial: A multicentre randomised placebo-controlled trial of intravenous paracetamol in intensive care unit patients with fever and infection

Critical Care and Resuscitation

Volumn 15, Issue 4, 2013, Pages 279-286

  Young, Paul J ^a,b   Weatherall, Mark ^c   Saxena, Manoj K ^d,e   Bellomo, Rinaldo ^f   Freebairn, Ross C ^g   Hammond, Naomi E ^d   van Haren, Frank M P ^h   Henderson, Seton J ⁱ   McArthur, Colin J ^j   McGuinness, Shay P ^j   Mackle, Diane ^a   Myburgh, John A ^d   Webb, Steve A R ^k   Beasley, Richard W ^b  

^a WELLINGTON HOSPITAL   (New Zealand)

^b MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^e ST GEORGE HOSPITAL   (Australia)

^f AUSTIN HOSPITAL   (Australia)

^g HAWKE S BAY HOSPITAL   (New Zealand)

^h CANBERRA HOSPITAL   (Australia)

ⁱ CHRISTCHURCH HOSPITAL   (New Zealand)

^j AUCKLAND CITY HOSPITAL   (New Zealand)

^k ROYAL PERTH HOSPITAL   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPYRETIC AGENT; PARACETAMOL;

ARTICLE; FEVER; HUMAN; INFECTION; INTENSIVE CARE; INTENSIVE CARE UNIT; INTENTION TO TREAT ANALYSIS; INTRAVENOUS ADMINISTRATION; METHODOLOGY; NEW ZEALAND; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL ANALYSIS;

ACETAMINOPHEN; ADMINISTRATION, INTRAVENOUS; ANTIPYRETICS; CLINICAL TRIALS, PHASE II AS TOPIC; CRITICAL CARE; DATA INTERPRETATION, STATISTICAL; FEVER; HUMANS; INFECTION; INTENSIVE CARE UNITS; INTENTION TO TREAT ANALYSIS; NEW ZEALAND; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84888424062     PISSN: 14412772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Young PJ, Saxena MK, Bellomo R, et al. The HEAT trial: a protocol for a multicentre randomised placebo-controlled trial of IV paracetamol in ICU patients with fever and infection. Crit Care Resusc 2012; 14: 290-6.
2. Finfer S, Cass A, Gallagher M, et al. The RENAL (Randomised Evaluation of Normal vs. Augmented Level of Replacement Therapy) study: statistical analysis plan. Crit Care Resusc 2009; 11: 58-66.
3. Finfer S, Heritier S. The NICE-SUGAR (Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation) Study: statistical analysis plan. Crit Care Resusc 2009; 11: 46-57.
4. Myburgh J, Li Q, Heritier S, et al. Statistical analysis plan for the Crystalloid Versus Hydroxyethyl Starch Trial (CHEST). Crit Care Resusc 2012; 14: 44-52.
5. Finfer S, Bellomo R. Why publish statistical analysis plans? Crit Care Resusc 2009; 11: 5-6.
6. Young P, Hodgson C, Dulhunty J, et al. End points for phase II trials in intensive care: recommendations from the Australian and New Zealand Clinical Trials Group consensus panel meeting. Crit Care Resusc 2012; 14: 211-5.
7. Niven DJ, Stelfox HT, Laupland KB. Antipyretic therapy in febrile critically ill adults: a systematic review and meta-analysis. J Crit Care 2013; 28: 303-10.
8. Jefferies S, Weatherall M, Young P, et al. The effect of antipyretic medications on mortality in critically ill patients with infection: a systematic review and meta-analysis. Crit Care Resusc 2011; 13: 125-31.
9. Young P, Saxena M, Eastwood GM, et al. Fever and fever management among intensive care patients with known or suspected infection: a multicentre prospective cohort study. Crit Care Resusc 2011; 13: 97-102.
10. Lehmann EL, D'Abrera HJM. Nonparametrics: statistical methods